Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | LAG3 |
| Upstream (Parents) |
|---|
| (<<) IL2RB → LAG3 |
| (<<) IFNG → LAG3 |
| (<<) PRF1 → LAG3 |
| (<<) SIRPG → LAG3 |
| Downstream (Children) |
|---|
| LAG3 → PARP12 (>>) |
| LAG3 → EMR1 (>>) |
| LAG3 → SYNRG (>>) |
| LAG3 → SLC38A10 (>>) |
| LAG3 → KLHDC7B (>>) |
| LAG3 → CSAG2///CSAG3 (>>) |
| LAG3 → IFNG (>>) |
| LAG3 → TAP2 (>>) |
| LAG3 → XKR4 (>>) |
| LAG3 → FAM122C (>>) |
| LAG3 → RFX5 (>>) |
| LAG3 → SOCS1 (>>) |
| LAG3 → FBXO6 (>>) |
| LAG3 → NUP210 (>>) |
| LAG3 → PRIC285 (>>) |
